About Jason Kralic
Form D filings for Tellus Therapeutics from 2021 to 2023 list Jason Kralic as president and chief executive officer, director.
Jason Kralic first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Jason Kralic in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jason Kralic works with at each company, as listed on that company's latest Form D.
Tellus Therapeutics, Inc. · Form D, Feb 21, 2023